If this is your first visit, be sure to
check out the FAQ by clicking the
link above. You may have to register
before you can post: click the register link above to proceed. To start viewing messages,
select the forum that you want to visit from the selection below.
If you're only keeping two RPs, I'd keep Pomeranz and Wick. I disagree on Richards, but will concur the shorter season increases the possibility you'll get value out of him.
Keep all the pitchers. Toss back Acuna. That guy sucks.
If I toss him, he'll go for $50+, and then you wouldn't be able to try to convince me to trade him to you. Tell you what...I'll consider tossing him if you toss Woodruff and Lamet.
If you're only keeping two RPs, I'd keep Pomeranz and Wick. I disagree on Richards, but will concur the shorter season increases the possibility you'll get value out of him.
No on Starling at $46.
Are you convinced that Wick will finish with more saves than Hudson? I'm just not sure about that one.
Are you convinced that Wick will finish with more saves than Hudson? I'm just not sure about that one.
I'm convinced Wick is lower risk with higher return potential. Logic:
- Even if Doolittle tanks at closer, there's no assurance Hudson does well, either. Hudson's xERA was 4.75 last year, and he hasn't reached the K level of one per inning for two years.
- I'm not even sold Hudson is the closer-in-waiting with the Nats dishing out $8 mil/year for Will Harris.
- Doolittle's stuff decline, IMO, is less steep than Kimbrel's.
- As you noted in an earlier post, Wick is the likely go-to if Kimbrel is OK, but gets hurt or needs a day off. He's clearly the closer-in-waiting with essentially no competition.
I'm convinced Wick is lower risk with higher return potential. Logic:
- Even if Doolittle tanks at closer, there's no assurance Hudson does well, either. Hudson's xERA was 4.75 last year, and he hasn't reached the K level of one per inning for two years.
- I'm not even sold Hudson is the closer-in-waiting with the Nats dishing out $8 mil/year for Will Harris.
- Doolittle's stuff decline, IMO, is less steep than Kimbrel's.
- As you noted in an earlier post, Wick is the likely go-to if Kimbrel is OK, but gets hurt or needs a day off. He's clearly the closer-in-waiting with essentially no competition.
Alright...you've convinced me, and I defer to the wisdom of the Pen. I will hedge my bets, though and keep both Hudson and Wick. Now my pitching strategy will be to draft two stud SPs and one solid closer for about $75 - $85 combined, which I think I can afford since I have seven pitching keepers for a total of $23.
(Definitely no extension for Fried nor Caleb, right?)
Alright...you've convinced me, and I defer to the wisdom of the Pen. I will hedge my bets, though and keep both Hudson and Wick. Now my pitching strategy will be to draft two stud SPs and one solid closer for about $75 - $85 combined, which I think I can afford since I have seven pitching keepers for a total of $23.
(Definitely no extension for Fried nor Caleb, right?)
We already discussed that’s what I was trying to do...though I was originally thinking two good pitchers and two cheap closers. Keeping Wick shifts more dollars into good starters and one good closer.
I'm convinced Wick is lower risk with higher return potential. Logic:
- Even if Doolittle tanks at closer, there's no assurance Hudson does well, either. Hudson's xERA was 4.75 last year, and he hasn't reached the K level of one per inning for two years.
- I'm not even sold Hudson is the closer-in-waiting with the Nats dishing out $8 mil/year for Will Harris.
- Doolittle's stuff decline, IMO, is less steep than Kimbrel's.
- As you noted in an earlier post, Wick is the likely go-to if Kimbrel is OK, but gets hurt or needs a day off. He's clearly the closer-in-waiting with essentially no competition.
I wound up hedging my bets a little, and picking up Jeffress via FAAB this weekend (which paid immediate dividends on Monday). Great call from you on Kimbrel, who looks very shaky to start. Crazy that my first two saves of the season have come from Jeffress & Pomeranz...but let’s hope it continues.
Comment